Isaku Okamoto

Head And Neck Surgery
Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Pain Associated With Head and Neck Cancer Photoimmunotherapy.

Pain Associated With Head and Neck Cancer Photoimmunotherapy.

Journal: In vivo (Athens, Greece)

Published: June 04, 2026

Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer.

Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer.

Journal: Anticancer research

Published: February 07, 2026

Utility of a Simplified Irradiator for Photosensitivity Testing in Head and Neck Photoimmunotherapy.

Utility of a Simplified Irradiator for Photosensitivity Testing in Head and Neck Photoimmunotherapy.

Journal: In vivo (Athens, Greece)

Published: January 23, 2026

Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial.

Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial.

Journal: Current oncology (Toronto, Ont.)

Published: December 17, 2025

Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status.

Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status.

Journal: Anticancer research

Published: December 16, 2025

Real-world outcomes of photoimmunotherapy for oral sites in head and neck cancer: A multicentre subgroup analysis.

Real-world outcomes of photoimmunotherapy for oral sites in head and neck cancer: A multicentre subgroup analysis.

Journal: Photodiagnosis and photodynamic therapy

Published: November 25, 2025

Genetic risk stratification and preventive strategies for double primary HNSCC and ESCC: a single-center cohort study.

Genetic risk stratification and preventive strategies for double primary HNSCC and ESCC: a single-center cohort study.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: September 04, 2025

Summary of Japanese clinical practice guidelines for head and neck cancer - 2025 update edited by the Japan Society for Head and Neck Cancer.

Summary of Japanese clinical practice guidelines for head and neck cancer - 2025 update edited by the Japan Society for Head and Neck Cancer.

Journal: Auris, nasus, larynx

Published: August 22, 2025

Clinical outcomes and prognostic significance of endoscopic laryngo-pharyngeal surgery for head and neck squamous cell carcinoma: a retrospective analysis of 111 cases.

Clinical outcomes and prognostic significance of endoscopic laryngo-pharyngeal surgery for head and neck squamous cell carcinoma: a retrospective analysis of 111 cases.

Journal: Surgical endoscopy

Published: July 30, 2025

Hematological Markers Predict Immune-Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Pembrolizumab.

Hematological Markers Predict Immune-Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Pembrolizumab.

Journal: Asia-Pacific journal of clinical oncology

Published: July 11, 2025

Real-World Effectiveness and Safety of Photoimmunotherapy for Head and Neck Cancer: A Multicenter Retrospective Study.

Real-World Effectiveness and Safety of Photoimmunotherapy for Head and Neck Cancer: A Multicenter Retrospective Study.

Journal: Cancers

Published: June 24, 2025

Papillary Thyroid Carcinoma Arising From a Thyroglossal Duct Cyst: A Case Report.

Papillary Thyroid Carcinoma Arising From a Thyroglossal Duct Cyst: A Case Report.

Journal: Cureus

Published: May 12, 2025

Showing 1-12 of 77

Last Updated: 09/26/2026